Pfizer Appoints Citi Analyst Andrew Baum as New Strategy Chief

1. Pfizer, one of the world's largest pharmaceutical companies, has appointed Andrew Baum as its new strategy chief.
2. Baum previously worked as an analyst at Citi, a leading global bank, where he covered the healthcare sector.
3. In his new role at Pfizer, Baum will be responsible for leading the company's strategic planning and decision-making processes.
4. The appointment of Baum marks a significant leadership change for Pfizer, as the company looks to navigate the rapidly evolving pharmaceutical industry.
5. Baum's expertise in healthcare analysis and strategic planning is expected to help Pfizer stay competitive and drive growth in the coming years.
6. Prior to joining Citi, Baum worked at other major financial institutions, including Morgan Stanley and Goldman Sachs.
7. Baum holds a degree in economics from the University of Cambridge and is a CFA charterholder.